A detailed history of Arrow Mark Colorado Holdings LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 1,492,062 shares of SWTX stock, worth $58.2 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
1,492,062
Previous 1,624,991 8.18%
Holding current value
$58.2 Million
Previous $61.2 Million 21.9%
% of portfolio
0.68%
Previous 0.81%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.04 - $42.76 $4.26 Million - $5.68 Million
-132,929 Reduced 8.18%
1,492,062 $47.8 Million
Q2 2024

Aug 14, 2024

SELL
$36.06 - $47.62 $3.51 Million - $4.64 Million
-97,386 Reduced 5.65%
1,624,991 $61.2 Million
Q1 2024

May 15, 2024

SELL
$36.5 - $52.5 $13.7 Million - $19.7 Million
-374,431 Reduced 17.86%
1,722,377 $84.8 Million
Q4 2023

Feb 14, 2024

SELL
$18.94 - $37.24 $7.59 Million - $14.9 Million
-400,985 Reduced 16.05%
2,096,808 $76.5 Million
Q2 2023

Aug 14, 2023

SELL
$23.15 - $32.71 $94,637 - $133,718
-4,088 Reduced 0.16%
2,497,793 $65.5 Million
Q1 2023

May 15, 2023

SELL
$24.97 - $34.05 $2.85 Million - $3.89 Million
-114,305 Reduced 4.37%
2,501,881 $64.4 Million
Q4 2022

Feb 14, 2023

BUY
$21.73 - $28.72 $1.42 Million - $1.88 Million
65,407 Added 2.56%
2,616,186 $68 Million
Q3 2022

Nov 14, 2022

SELL
$24.1 - $39.66 $18 Million - $29.6 Million
-745,571 Reduced 22.62%
2,550,779 $72.8 Million
Q2 2022

Aug 15, 2022

BUY
$18.36 - $60.07 $36 Million - $118 Million
1,958,553 Added 146.4%
3,296,350 $81.2 Million
Q1 2022

May 16, 2022

BUY
$48.97 - $65.46 $11.2 Million - $14.9 Million
228,039 Added 20.55%
1,337,797 $75.5 Million
Q4 2021

Feb 14, 2022

BUY
$53.3 - $75.84 $349,328 - $497,055
6,554 Added 0.59%
1,109,758 $68.8 Million
Q3 2021

Nov 15, 2021

BUY
$62.66 - $88.26 $919,034 - $1.29 Million
14,667 Added 1.35%
1,103,204 $70 Million
Q2 2021

Aug 16, 2021

SELL
$67.45 - $85.63 $3.78 Million - $4.8 Million
-56,067 Reduced 4.9%
1,088,537 $89.7 Million
Q1 2021

May 17, 2021

SELL
$65.1 - $93.59 $9.35 Million - $13.4 Million
-143,696 Reduced 11.15%
1,144,604 $84.2 Million
Q4 2020

Feb 16, 2021

BUY
$48.36 - $77.92 $24.7 Million - $39.8 Million
510,298 Added 65.59%
1,288,300 $93.4 Million
Q3 2020

Nov 16, 2020

SELL
$36.14 - $51.99 $3.44 Million - $4.96 Million
-95,309 Reduced 10.91%
778,002 $37.1 Million
Q2 2020

Aug 24, 2020

BUY
$22.98 - $48.57 $20.1 Million - $42.4 Million
873,311 New
873,311 $36.7 Million
Q2 2020

Aug 14, 2020

SELL
$22.98 - $48.57 $10.6 Million - $22.4 Million
-461,071 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$20.44 - $41.21 $61,176 - $123,341
2,993 Added 0.65%
461,071 $12.4 Million
Q4 2019

Feb 14, 2020

BUY
$17.74 - $39.52 $854,819 - $1.9 Million
48,186 Added 11.76%
458,078 $17.6 Million
Q3 2019

Nov 14, 2019

BUY
$18.8 - $27.82 $7.71 Million - $11.4 Million
409,892 New
409,892 $8.89 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.43B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.